MichaelR.GreverMD

PubMed

• Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemia.
  Nilesh Kapoor, Qiuhong Zhao, Andrew Stiff, Seema A Bhat, Mirela I Anghelina
  Ejhaem. 2024-10-01
• 1 citations
  Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation.
  John Alan Gambril, Sanam M Ghazi, Stephen Sansoterra, Mussammat Ferdousi, Onaopepo Kola-Kehinde
  Leukemia. 2024-10-01
• 3 citations
  Hairy cell leukemia variant and WHO classification correspondence Re: 5edition WHO classification haematolymphoid tumors: lymphoid neoplasms.
  Michael Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji
  Leukemia. 2024-07-01

Abstracts/Posters

• Resistance to Acalabrutinib in CLL Is Mediated Primarily By BTK Mutations
  Michael R. Grever, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Final Results of a Phase 2 Trial of Early Intervention Ibrutinib with Vaccinations in Patients with Asymptomatic, High-Risk CLL
  Michael R. Grever, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Final Results of a Phase 2 Trial of Early Intervention Ibrutinib with Vaccinations in Patients with Asymptomatic, High-Risk CLL
  Michael R. Grever, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Challenges In Management Of Hairy Cell Leukemia In 2019 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Infection at the Time of Initial Therapy for Hairy Cell Leukemia Is Associated with Inferior Time to Next Treatment 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018